TickerFiles

BALCHEM CORP

Nasdaq · CIK 0000009326 · Fiscal year end 1231

BCPC

Latest reported period: Latest published period

Revenue

$270.7M

Cost Of Revenue

$169.6M

Gross Profit

$101.1M

Recent financials

MetricCurrentPriorChange
Revenue$270.7M--
Cost Of Revenue$169.6M--
Gross Profit$101.1M--
Operating Income$55.6M--
Net Income$40.3M--
Eps Basic1.26--
Eps Diluted1.25--
Cash And Equivalents$72.9M--
Total Assets$1.7B--
Total Liabilities$408.6M--
Shareholders Equity$1.3B--
Operating Cash Flow$40.1M--

Latest filings

FormCompanyFiledAccession
10-QBALCHEM CORP2026-04-300000009326-26-000018
10-KBALCHEM CORP2026-02-200000009326-26-000007
4BALCHEM CORP2026-02-130001140361-26-005544
4BALCHEM CORP2026-02-130001140361-26-005542
4BALCHEM CORP2026-02-130001140361-26-005536
4BALCHEM CORP2026-02-130001140361-26-005533
4BALCHEM CORP2026-02-130001140361-26-005531
4BALCHEM CORP2026-02-130001140361-26-005520
4BALCHEM CORP2026-02-130001140361-26-005516
4BALCHEM CORP2026-02-130001140361-26-005512
4BALCHEM CORP2026-02-130001140361-26-005510
4BALCHEM CORP2026-02-130001140361-26-005434
4BALCHEM CORP2026-02-130001140361-26-005433
4BALCHEM CORP2026-02-130001140361-26-005436
4BALCHEM CORP2026-02-130001140361-26-005432
4BALCHEM CORP2026-02-130001140361-26-005431
4BALCHEM CORP2026-02-130001140361-26-005435
4BALCHEM CORP2026-02-100001140361-26-004642
4BALCHEM CORP2026-02-100001140361-26-004619
4BALCHEM CORP2026-02-100001140361-26-004618
4BALCHEM CORP2026-02-100001140361-26-004614
4BALCHEM CORP2026-02-100001140361-26-004617
4BALCHEM CORP2026-02-100001140361-26-004616
4BALCHEM CORP2026-02-100001140361-26-004615
4BALCHEM CORP2026-02-100001140361-26-004613
4BALCHEM CORP2026-02-100001140361-26-004612
4BALCHEM CORP2025-12-050001140361-25-044554
4BALCHEM CORP2025-12-050001140361-25-044551
4BALCHEM CORP2025-11-130001140361-25-041986
4BALCHEM CORP2025-11-030001140361-25-040195
4BALCHEM CORP2025-10-220001140361-25-038951
10-QBALCHEM CORP2025-10-210000009326-25-000022
10-QBALCHEM CORP2025-07-310000009326-25-000014